Search results for "OUTCOME"

showing 10 items of 5148 documents

A multicenter, double-blind, randomized, placebo-controlled trial of the β3-adrenoceptor agonist solabegron for overactive bladder

2012

Abstract Background β-Adrenoceptor agonists are effective in animal models of bladder dysfunction, and the human bladder primarily expresses the β3 receptor subtype. Objective To evaluate the efficacy and tolerability of the highly selective and potent β3-adrenoceptor agonist solabegron in a clinical proof-of-concept study in incontinent women with overactive bladder (OAB). Design, setting, and participants This was a randomized, double-blind trial in adult women with OAB (one or more 24-h incontinence episodes and eight or more average 24-h micturitions). Interventions Solabegron 50mg ( n =88), solabegron 125mg ( n =85), or placebo ( n =85)—all twice daily—were administered. Outcome measur…

Adultmedicine.medical_specialtyTime FactorsUrologymedia_common.quotation_subjectUrinary BladderArgentinaTaiwanPlacebo-controlled studyUrologyUrinationAdrenergic beta-3 Receptor AgonistsPlaceboBenzoatesUrinationDrug Administration ScheduleSouth AfricaYoung AdultSolabegronDouble-Blind MethodRepublic of KoreamedicineHumansAgedmedia_commonAniline CompoundsUrinary Bladder Overactivebusiness.industryBiphenyl CompoundsAustraliaMiddle Agedmedicine.diseaseEuropeUrodynamicsTreatment OutcomeUrinary IncontinenceBlood pressureOveractive bladderTolerabilityAmbulatoryLinear ModelsFemalebusinessNew Zealandmedicine.drugEuropean urology
researchProduct

A 4-year study of the efficacy and tolerability of enzyme replacement therapy with agalsidase alfa in 36 women with Fabry disease

2009

Although Fabry disease is X linked and considered to affect primarily male hemizygotes, female heterozygotes may experience all the signs and symptoms of this metabolic disorder. This prospective, single-center, open-label, clinical trial was performed to evaluate the long-term response of female patients with Fabry disease to enzyme replacement therapy.Symptomatic women (average age = 47 years) enrolled in this 4-year study were treated with agalsidase alfa (Replagal, Shire HGT, Inc.) at a dose of 0.2 mg/kg, every other week for 4 years (N = 36). Clinical and biochemical assessments were conducted at 12-month intervals.The Mainz Severity Score Index, a measure of total disease burden, was …

Adultmedicine.medical_specialtyTreatment outcomeSeverity of Illness IndexDrug Administration ScheduleYoung Adultstomatognathic systemInternal medicineSeverity of illnessLeukocytesmedicineHumansProspective StudiesProspective cohort studyGenetics (clinical)AgedAnalysis of Variancebusiness.industryvirus diseasesEnzyme replacement therapyMiddle Agedmedicine.diseaseFabry diseaseRecombinant Proteinsdigestive system diseasesIsoenzymesClinical trialTreatment OutcomeTolerabilityalpha-GalactosidaseMutationPhysical therapyFabry DiseaseFemalebusinessAgalsidase alfaGlomerular Filtration RateGenetics in Medicine
researchProduct

Use of the Martius advancement flap for low rectovaginal fistulas

2019

Aim: The percentage recurrence after any surgical treatment for low rectovaginal fistula (LRVF) is unacceptably high. The aim of this study was to evaluate the short- and long-term results of the Martius procedure in a carefully selected series of patients with a LRVF of at least 1 cm diameter who had had at least two previous surgeries or in the presence of chronically inflamed local tissues. Method: Between January 2009 and April 2017, 24 patients with the abovementioned features were prospectively included in this study. Success was defined both as the absence of any subjective symptoms and the fistula, as confirmed by evaluation under anaesthesia. Postoperative complications were assess…

Adultmedicine.medical_specialtyUnder anaesthesiaFistulaOperative Timequality of sexual lifeSurgical Flaps03 medical and health sciencesPostoperative Complications0302 clinical medicineQuality of lifeRecurrencemartius flapmedicineHumansdiversion stomaMajor complicationSurgical treatmentdiversion stoma; low rectovaginal fistulas; martius flap; quality of life; quality of sexual life; recurrent rectovaginal fistulasLow rectovaginal fistulabusiness.industryrecurrent rectovaginal fistulasRectovaginal FistulaGastroenterologyLength of StayMiddle Agedmedicine.diseaseSurgerySexual Dysfunction PhysiologicalTreatment OutcomeUrinary Incontinencequality of lifeRectovaginal fistula030220 oncology & carcinogenesisFemale sexual functionSexual lifeFemale030211 gastroenterology & hepatologylow rectovaginal fistulasbusiness
researchProduct

Transobturator suburethral tape in the treatment of stress urinary incontinence: efficacy and quality of life after 5 year follow up.

2013

Abstract Objectives Stress urinary incontinence (SUI) is a highly prevalent dysfunction in middle-aged and elderly women. One recent technique places a sub-urethral tape passed through the transobturator foramen. Efficacy and quality of life were assessed after five years of treatment with the transobturator technique in women suffering SUI. This evaluation followed a previous control at the first year post-intervention. Study design Sixty-three women were assessed five years after operation with the transobturator technique. Additionally, twenty-nine women of these women had undergone pelvic floor reconstruction due to different forms of genital prolapse. Quality of life (QoL) was assessed…

Adultmedicine.medical_specialtyUrinary urgencyUrge urinary incontinenceUrinary Incontinence StressUrinary incontinenceGeneral Biochemistry Genetics and Molecular BiologyPelvic Organ ProlapseStatistics NonparametricQuality of lifeRecurrenceSurveys and QuestionnairesmedicineHumansSex organAgedGynecologyAged 80 and overSuburethral SlingsGenitourinary systembusiness.industryObstetrics and GynecologyUrinary Incontinence UrgeMiddle AgedSurgeryDistressLogistic ModelsTreatment OutcomeQuality of LifeFemalemedicine.symptombusinessBody mass indexFollow-Up StudiesMaturitas
researchProduct

Sexual Function and Fertility of Women with Classic Bladder Exstrophy and Continent Urinary Diversion

2015

We evaluated the outcome in female patients with classic bladder exstrophy and continent urinary diversion for sexual function and fertility.We reviewed the medical records of female exstrophy patients who underwent continent urinary diversion in our department between 1969 and 2014. Patients were invited for followup examination and asked to complete questionnaires relating to sexual function, social integration and maternity.Of 38 eligible patients 29 (response rate 76%) with a followup of 22.3 years were included in study. Primary continent urinary diversion was done in 62% of patients and 38% underwent secondary continent urinary diversion after failed reconstruction of the exstrophic b…

Adultmedicine.medical_specialtyUrologymedicine.medical_treatmentmedia_common.quotation_subject030232 urology & nephrologyFertilityHuman sexualityUrinary DiversionPelvic Organ Prolapse03 medical and health sciencesPostoperative Complications0302 clinical medicineRisk FactorsmedicineHumansRetrospective Studiesmedia_common030219 obstetrics & reproductive medicinebusiness.industryIncidenceGeneral surgeryBladder ExstrophyUrinary Reservoirs ContinentUrinary diversionRetrospective cohort studyMiddle Agedmedicine.diseaseSurgeryBladder exstrophySexual Dysfunction PhysiologicalTreatment OutcomeSexual dysfunctionFemalemedicine.symptomSexual functionbusinessInfertility Femalehuman activitiesContinent Urinary DiversionFollow-Up StudiesJournal of Urology
researchProduct

Ulipristal acetate versus leuprolide acetate for uterine fibroids

2012

A b s t r ac t Background The efficacy and side-effect profile of ulipristal acetate as compared with those of leuprolide acetate for the treatment of symptomatic uterine fibroids before surgery are unclear. Methods In this double-blind noninferiority trial, we randomly assigned 307 patients with symptomatic fibroids and excessive uterine bleeding to receive 3 months of daily therapy with oral ulipristal acetate (at a dose of either 5 mg or 10 mg) or once-monthly intramuscular injections of leuprolide acetate (at a dose of 3.75 mg). The primary outcome was the proportion of patients with controlled bleeding at week 13, with a prespecified noninferiority margin of −20%. Results Uterine bleed…

Adultmedicine.medical_specialtyUterine fibroidsIntention to Treat AnalysiUrologyAdministration OralEndometriumInjections Intramuscularlaw.inventionchemistry.chemical_compoundYoung AdultEndometriumPrimary outcomeRandomized controlled trialDouble-Blind MethodlawUlipristal acetateSelective progesterone receptor modulatormedicineUterine NeoplasmUlipristalMenorrhagiaGynecologyIntention-to-treat analysisLeiomyomabusiness.industryObstetrics and GynecologyUterine bleedingUterine fibroids uterine leiomyomas uterine bleeding ulipristal acetate leuprolide acetate medical therapyGeneral MedicineNorpregnadieneMiddle Agedmedicine.diseaseSettore MED/40 - Ginecologia E Ostetriciamedicine.anatomical_structurechemistryAmenorrheaFemalemedicine.symptomLeuprolidebusinessHuman
researchProduct

Changes in a patient with neck pain after application of ischemic compression as a trigger point therapy

2010

Objective To describe the immediate effects of ischemic compression (IC) as a trigger point therapy in a case of a patient with neck pain. The application of IC is a safe and effective method to successfully treat elicited myofascial trigger points. The purpose of this method is to deliberate the blockage of blood in a trigger point area in order to increase local blood flow. This washes away waste products, supplies necessary oxygen and helps the affected tissue to heal. In this case study, we treated a 27-year-old female patient with a medical report of neck pain for at least four months. The physical examination revealed a neck pain and stiffness at the left side and pain increases when …

Adultmedicine.medical_specialtyVisual analogue scalePhysical Therapy Sports Therapy and RehabilitationElectromyographyPain.Neck MusclesSistema musculoesquelético - Heridas y lesiones - Tratamiento.medicineHumansOrthopedics and Sports MedicineMyofascial pain syndromes - Treatment.Sindrome de dolor miofascial - Tratamiento.Dolor.Myofascial Pain SyndromesRachisPain MeasurementMyofascial trigger pointNeck painNeck Painmedicine.diagnostic_testbusiness.industryNeck - Muscles - Wounds and injuries - Treatment.Rehabilitationmedicine.diseaseMusculoskeletal ManipulationsSurgeryTreatment OutcomeAnesthesiaIschemic CompressionCuello - Músculos - Heridas y lesiones - Tratamiento.Femalemedicine.symptomMusculoskeletal system - Wounds and injuries - Treatment.Ultrasonidos - Uso terapeútico.Trapezius musclebusinessRange of motionUltrasonics - Therapeutic use.
researchProduct

Impact of Thoracic Endografting on the Hemodynamics of the Native Aorta: Pre- and Postoperative Assessments of Wall Shear Stress and Vorticity Using …

2021

Purpose To quantify the hemodynamic consequences of thoracic endovascular aortic repair (TEVAR) by comparing the preoperative and postoperative wall shear stress (WSS) and vorticity profiles on computational fluid dynamics (CFD) simulations. Materials and Methods The pre- and postoperative computed tomography (CT) scans from 20 consecutive patients (median age 69 years, range 20–87) treated for different thoracic aortic pathologies (11 aneurysms, 5 false aneurysms, 3 penetrating ulcers, and 1 traumatic aortic rupture) were segmented to construct patient-specific CFD models using a meshless code. The simulations were run over the cardiac cycle, and the WSS and vorticity values measured at th…

Adultmedicine.medical_specialty[SDV]Life Sciences [q-bio]HemodynamicsAorta Thoracic030204 cardiovascular system & hematologyComputational fluid dynamicsAortic repair030218 nuclear medicine & medical imaging03 medical and health sciencesYoung Adult0302 clinical medicinemedicine.arteryInternal medicineShear stressmedicineThoracic aortaHumansRadiology Nuclear Medicine and imagingComputingMilieux_MISCELLANEOUSAortaAgedAged 80 and overAortabusiness.industryHemodynamicsModels CardiovascularVorticityMiddle AgedTreatment Outcomecardiovascular systemCardiologyHydrodynamicsSurgeryStentsCardiology and Cardiovascular MedicinebusinessJournal of endovascular therapy : an official journal of the International Society of Endovascular Specialists
researchProduct

Limited implantation success of direct-cleaved human zygotes: a time-lapse study.

2012

Objective To evaluate embryos with direct cleavage (≤5 hours) from two to three cells (DC2–3) and correlate this morphokinetic parameter to implantation and ongoing pregnancy. Design Clinical multicenter retrospective study. Setting Private in vitro fertilization (IVF) centers. Patient(s) From three clinics, a total of 979 treatments including 5,225 embryos using autologous or donated oocytes, of which 1,659 embryos were transferred. Intervention(s) None. Main Outcome Measure(s) Clinical pregnancy confirmed by ultrasound in week 7. Result(s) Of the total embryo cohort, 715 (13.7%) underwent direct cleavage from two to three cells, 1,659 embryos were transferred to recipients, and 109 of the…

Adultmedicine.medical_specialtyanimal structuresPregnancy RateZygoteDenmarkBiologyCleavage (embryo)Young AdultHuman fertilizationPregnancymedicineHumansEmbryo ImplantationGynecologyPregnancyZygoteEmbryogenesisObstetrics and GynecologyEmbryomedicine.diseaseEmbryo TransferPregnancy rateTreatment OutcomeReproductive MedicineSpainembryonic structuresFemaleImplantFertility and sterility
researchProduct

VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY

2008

Summary.  Background: Combined vitamin K-dependent clotting factor (VKCF) deficiency type 2 (VKCFD2) is a rare bleeding disorder caused by mutated vitamin K 2,3-epoxide reductase complex subunit 1 (VKORC1) gene. Methods and results: An Italian patient with moderate to severe bleeding tendency was genotyped, and found to be homozygous for the unique VKORC1 mutation (Arg98Trp) so far detected in VKCFD2. The activity levels of VKCFs were differentially reduced, and inversely related to the previously estimated affinity of procoagulant factor propeptides for the γ-carboxylase. The normal (factor IX) or reduced antigen levels (other VKCFs) produced a gradient in specific activities. Vitamin K su…

Adultmedicine.medical_specialtycoagulation factor levelsVitamin KProtein SMixed Function OxygenasesTissue factorchemistry.chemical_compoundInternal medicineVitamin K Epoxide ReductasesmedicineVKCFD2HumansFactor IXClotting factorCoagulation factor levels; Thrombin generation; Vitamin K supplementation; VKCFD2; VKORC1 mutation;biologyFactor VIIChemistryFactor XHomozygotevitamin K supplementationHematologyBlood Coagulation DisordersEndocrinologyTreatment OutcomeCoagulationthrombin generationImmunologyMutationbiology.proteinFemaleBlood Coagulation TestsVKCFD2 VKORC1 mutation coagulation factor levels thrombin generation vitamin K supplementationProtein Cmedicine.drugHalf-LifeVKORC1 mutation
researchProduct